Structurally diverse polydopamine-based nanomedicines for cancer therapy

Announcing a new publication for Acta Materia Medica journal. Mussel-inspired polydopamine (PDA) has attracted substantial interest in materials synthesis, energy storage, environmental governance, and biomedical science since it was first reported in 2007. PDA, owing to its excellent biocompatibility and photothermal conversion efficiency (η), has been used in photothermal therapy alone and in combination with photodynamic therapy, chemotherapy, radiation therapy, immunotherapy, and gas therapy for cancer treatment. This review article summarizes the methods for synthesizing structurally diverse PDA-based nanomedicines and their applications in cancer therapy, to provide perspectives to guide future studies in cancer treatment.

Keywords: polydopamine, nanomedicine, photothermal therapy, synergistic therapies, cancer treatment

Acta Materia Medica welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.

Submission Process

Submissions to Acta Materia Medica are made using ScholarOne, the online submission and peer review system. Registration and access are available at

Queries about the journal can be sent to

Please visit to learn more about the journal.

Editorial Board:

There are no author submission or article processing fees.

Follow Acta Materia Medica on Twitter; Facebook (

eISSN 2737-7946

Article Reference: Yuhan Zheng, Tao Cao and Xuan Han et al. Structurally diverse polydopamine-based nanomedicines for cancer therapy. Acta Materia Medica. Vol. 1(4):17-34. DOI: 10.15212/AMM-2022-0023